nodes	percent_of_prediction	percent_of_DWPC	metapath
Aripiprazole—HTR3A—enteric nervous system—Crohn's disease	0.0365	0.171	CbGeAlD
Aripiprazole—HTR3A—myenteric nerve plexus—Crohn's disease	0.0276	0.13	CbGeAlD
Aripiprazole—HTR7—enteric nervous system—Crohn's disease	0.0236	0.111	CbGeAlD
Aripiprazole—HTR7—myenteric nerve plexus—Crohn's disease	0.0179	0.084	CbGeAlD
Aripiprazole—CHRM3—muscle of abdomen—Crohn's disease	0.0157	0.0738	CbGeAlD
Aripiprazole—HTR2A—enteric nervous system—Crohn's disease	0.0147	0.0691	CbGeAlD
Aripiprazole—HTR2A—myenteric nerve plexus—Crohn's disease	0.0112	0.0524	CbGeAlD
Aripiprazole—CHRM5—epithelium—Crohn's disease	0.00335	0.0157	CbGeAlD
Aripiprazole—CHRM5—skin of body—Crohn's disease	0.00318	0.0149	CbGeAlD
Aripiprazole—HTR7—mouth—Crohn's disease	0.00306	0.0144	CbGeAlD
Aripiprazole—DRD5—lymphoid tissue—Crohn's disease	0.00287	0.0135	CbGeAlD
Aripiprazole—H1F0—smooth muscle tissue—Crohn's disease	0.00278	0.0131	CbGeAlD
Aripiprazole—H1F0—skin of body—Crohn's disease	0.00274	0.0129	CbGeAlD
Aripiprazole—H1F0—mammalian vulva—Crohn's disease	0.0025	0.0118	CbGeAlD
Aripiprazole—H1F0—lymphoid tissue—Crohn's disease	0.00222	0.0104	CbGeAlD
Aripiprazole—H1F0—digestive system—Crohn's disease	0.0022	0.0103	CbGeAlD
Aripiprazole—HTR3A—digestive system—Crohn's disease	0.00209	0.00983	CbGeAlD
Aripiprazole—HTR2B—smooth muscle tissue—Crohn's disease	0.002	0.00941	CbGeAlD
Aripiprazole—HTR2B—skin of body—Crohn's disease	0.00198	0.00929	CbGeAlD
Aripiprazole—CHRM3—smooth muscle tissue—Crohn's disease	0.0018	0.00846	CbGeAlD
Aripiprazole—HTR7—epithelium—Crohn's disease	0.00178	0.00836	CbGeAlD
Aripiprazole—ADRA1A—epithelium—Crohn's disease	0.00172	0.00806	CbGeAlD
Aripiprazole—HTR7—smooth muscle tissue—Crohn's disease	0.00172	0.00806	CbGeAlD
Aripiprazole—SLC6A4—digestive system—Crohn's disease	0.0016	0.0075	CbGeAlD
Aripiprazole—HTR2B—digestive system—Crohn's disease	0.00158	0.00743	CbGeAlD
Aripiprazole—CHRM3—digestive system—Crohn's disease	0.00142	0.00668	CbGeAlD
Aripiprazole—ADRA2C—mammalian vulva—Crohn's disease	0.00142	0.00667	CbGeAlD
Aripiprazole—HTR7—digestive system—Crohn's disease	0.00135	0.00636	CbGeAlD
Aripiprazole—HRH1—epithelium—Crohn's disease	0.00133	0.00624	CbGeAlD
Aripiprazole—ADRA1A—lymphoid tissue—Crohn's disease	0.00132	0.00621	CbGeAlD
Aripiprazole—HRH1—smooth muscle tissue—Crohn's disease	0.00128	0.00602	CbGeAlD
Aripiprazole—H1F0—lymph node—Crohn's disease	0.00125	0.00589	CbGeAlD
Aripiprazole—HRH1—mammalian vulva—Crohn's disease	0.00115	0.00542	CbGeAlD
Aripiprazole—ADRA2A—mammalian vulva—Crohn's disease	0.00113	0.00532	CbGeAlD
Aripiprazole—HTR2A—epithelium—Crohn's disease	0.00111	0.00521	CbGeAlD
Aripiprazole—HTR2A—smooth muscle tissue—Crohn's disease	0.00107	0.00502	CbGeAlD
Aripiprazole—CYP3A5—digestive system—Crohn's disease	0.00104	0.00489	CbGeAlD
Aripiprazole—HRH1—digestive system—Crohn's disease	0.00101	0.00475	CbGeAlD
Aripiprazole—HTR2B—lymph node—Crohn's disease	0.000904	0.00424	CbGeAlD
Aripiprazole—HTR2A—digestive system—Crohn's disease	0.000845	0.00397	CbGeAlD
Aripiprazole—CYP3A4—digestive system—Crohn's disease	0.000782	0.00367	CbGeAlD
Aripiprazole—CYP2D6—digestive system—Crohn's disease	0.00077	0.00361	CbGeAlD
Aripiprazole—ABCB1—epithelium—Crohn's disease	0.000728	0.00342	CbGeAlD
Aripiprazole—KCNH2—lymph node—Crohn's disease	0.000721	0.00338	CbGeAlD
Aripiprazole—ADRA2C—lymph node—Crohn's disease	0.000711	0.00334	CbGeAlD
Aripiprazole—Arthropathy—Prednisone—Crohn's disease	0.000685	0.00134	CcSEcCtD
Aripiprazole—Hepatobiliary disease—Azathioprine—Crohn's disease	0.000684	0.00133	CcSEcCtD
Aripiprazole—Pollakiuria—Mesalazine—Crohn's disease	0.000683	0.00133	CcSEcCtD
Aripiprazole—Agranulocytosis—Azathioprine—Crohn's disease	0.000675	0.00132	CcSEcCtD
Aripiprazole—Photosensitivity reaction—Mesalazine—Crohn's disease	0.000675	0.00131	CcSEcCtD
Aripiprazole—Decreased appetite—Mercaptopurine—Crohn's disease	0.000673	0.00131	CcSEcCtD
Aripiprazole—Weight increased—Mesalazine—Crohn's disease	0.000673	0.00131	CcSEcCtD
Aripiprazole—Weight decreased—Mesalazine—Crohn's disease	0.000669	0.0013	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.000669	0.0013	CcSEcCtD
Aripiprazole—Leukocytosis—Prednisone—Crohn's disease	0.000663	0.00129	CcSEcCtD
Aripiprazole—Pneumonia—Mesalazine—Crohn's disease	0.000663	0.00129	CcSEcCtD
Aripiprazole—Infestation NOS—Mesalazine—Crohn's disease	0.000659	0.00128	CcSEcCtD
Aripiprazole—Infestation—Mesalazine—Crohn's disease	0.000659	0.00128	CcSEcCtD
Aripiprazole—Ulcer—Prednisone—Crohn's disease	0.000659	0.00128	CcSEcCtD
Aripiprazole—Hypercholesterolaemia—Prednisone—Crohn's disease	0.000659	0.00128	CcSEcCtD
Aripiprazole—Depression—Mesalazine—Crohn's disease	0.000657	0.00128	CcSEcCtD
Aripiprazole—Cataract—Prednisone—Crohn's disease	0.000655	0.00128	CcSEcCtD
Aripiprazole—Haemoglobin—Azathioprine—Crohn's disease	0.000653	0.00127	CcSEcCtD
Aripiprazole—Haemorrhage—Azathioprine—Crohn's disease	0.000649	0.00127	CcSEcCtD
Aripiprazole—Renal failure—Mesalazine—Crohn's disease	0.000648	0.00126	CcSEcCtD
Aripiprazole—Neuropathy peripheral—Mesalazine—Crohn's disease	0.000646	0.00126	CcSEcCtD
Aripiprazole—Stomatitis—Mesalazine—Crohn's disease	0.000642	0.00125	CcSEcCtD
Aripiprazole—Jaundice—Mesalazine—Crohn's disease	0.000642	0.00125	CcSEcCtD
Aripiprazole—Conjunctivitis—Mesalazine—Crohn's disease	0.000641	0.00125	CcSEcCtD
Aripiprazole—Urinary tract infection—Mesalazine—Crohn's disease	0.000641	0.00125	CcSEcCtD
Aripiprazole—Sweating—Mesalazine—Crohn's disease	0.000632	0.00123	CcSEcCtD
Aripiprazole—ABCB1—mammalian vulva—Crohn's disease	0.000631	0.00296	CbGeAlD
Aripiprazole—Haematuria—Mesalazine—Crohn's disease	0.000628	0.00122	CcSEcCtD
Aripiprazole—Hiccups—Prednisone—Crohn's disease	0.000623	0.00121	CcSEcCtD
Aripiprazole—Hepatobiliary disease—Mesalazine—Crohn's disease	0.000623	0.00121	CcSEcCtD
Aripiprazole—Epistaxis—Mesalazine—Crohn's disease	0.000622	0.00121	CcSEcCtD
Aripiprazole—Sinusitis—Mesalazine—Crohn's disease	0.000618	0.0012	CcSEcCtD
Aripiprazole—Agranulocytosis—Mesalazine—Crohn's disease	0.000615	0.0012	CcSEcCtD
Aripiprazole—Body temperature increased—Mercaptopurine—Crohn's disease	0.000612	0.00119	CcSEcCtD
Aripiprazole—Haemoglobin—Mesalazine—Crohn's disease	0.000595	0.00116	CcSEcCtD
Aripiprazole—Rhinitis—Mesalazine—Crohn's disease	0.000593	0.00116	CcSEcCtD
Aripiprazole—Fluid retention—Prednisone—Crohn's disease	0.000592	0.00115	CcSEcCtD
Aripiprazole—Haemorrhage—Mesalazine—Crohn's disease	0.000592	0.00115	CcSEcCtD
Aripiprazole—Hepatitis—Mesalazine—Crohn's disease	0.000592	0.00115	CcSEcCtD
Aripiprazole—Pharyngitis—Mesalazine—Crohn's disease	0.000587	0.00114	CcSEcCtD
Aripiprazole—Immune system disorder—Azathioprine—Crohn's disease	0.000587	0.00114	CcSEcCtD
Aripiprazole—Mediastinal disorder—Azathioprine—Crohn's disease	0.000585	0.00114	CcSEcCtD
Aripiprazole—Neuropathy—Prednisone—Crohn's disease	0.000585	0.00114	CcSEcCtD
Aripiprazole—Urinary tract disorder—Mesalazine—Crohn's disease	0.000584	0.00114	CcSEcCtD
Aripiprazole—Oedema peripheral—Mesalazine—Crohn's disease	0.000583	0.00114	CcSEcCtD
Aripiprazole—Chills—Azathioprine—Crohn's disease	0.000583	0.00114	CcSEcCtD
Aripiprazole—Connective tissue disorder—Mesalazine—Crohn's disease	0.000581	0.00113	CcSEcCtD
Aripiprazole—Urethral disorder—Mesalazine—Crohn's disease	0.00058	0.00113	CcSEcCtD
Aripiprazole—HRH1—lymph node—Crohn's disease	0.000578	0.00271	CbGeAlD
Aripiprazole—Alopecia—Azathioprine—Crohn's disease	0.000574	0.00112	CcSEcCtD
Aripiprazole—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000571	0.00111	CcSEcCtD
Aripiprazole—Oesophagitis—Prednisone—Crohn's disease	0.00057	0.00111	CcSEcCtD
Aripiprazole—ADRA2A—lymph node—Crohn's disease	0.000567	0.00266	CbGeAlD
Aripiprazole—Ecchymosis—Prednisone—Crohn's disease	0.000564	0.0011	CcSEcCtD
Aripiprazole—ABCB1—lymphoid tissue—Crohn's disease	0.00056	0.00263	CbGeAlD
Aripiprazole—Pulmonary oedema—Prednisone—Crohn's disease	0.000555	0.00108	CcSEcCtD
Aripiprazole—ABCB1—digestive system—Crohn's disease	0.000554	0.0026	CbGeAlD
Aripiprazole—Eye disorder—Mesalazine—Crohn's disease	0.000553	0.00108	CcSEcCtD
Aripiprazole—Tinnitus—Mesalazine—Crohn's disease	0.000552	0.00107	CcSEcCtD
Aripiprazole—Cardiac disorder—Mesalazine—Crohn's disease	0.000549	0.00107	CcSEcCtD
Aripiprazole—Hyperkinesia—Prednisone—Crohn's disease	0.000544	0.00106	CcSEcCtD
Aripiprazole—Angiopathy—Mesalazine—Crohn's disease	0.000537	0.00105	CcSEcCtD
Aripiprazole—Euphoric mood—Prednisone—Crohn's disease	0.000536	0.00104	CcSEcCtD
Aripiprazole—Immune system disorder—Mesalazine—Crohn's disease	0.000534	0.00104	CcSEcCtD
Aripiprazole—Mediastinal disorder—Mesalazine—Crohn's disease	0.000533	0.00104	CcSEcCtD
Aripiprazole—Chills—Mesalazine—Crohn's disease	0.000531	0.00103	CcSEcCtD
Aripiprazole—Diarrhoea—Mercaptopurine—Crohn's disease	0.00053	0.00103	CcSEcCtD
Aripiprazole—Ill-defined disorder—Azathioprine—Crohn's disease	0.000525	0.00102	CcSEcCtD
Aripiprazole—Alopecia—Mesalazine—Crohn's disease	0.000523	0.00102	CcSEcCtD
Aripiprazole—Thrombophlebitis—Prednisone—Crohn's disease	0.000523	0.00102	CcSEcCtD
Aripiprazole—Anaemia—Azathioprine—Crohn's disease	0.000523	0.00102	CcSEcCtD
Aripiprazole—Diabetes mellitus—Prednisone—Crohn's disease	0.00052	0.00101	CcSEcCtD
Aripiprazole—Mental disorder—Mesalazine—Crohn's disease	0.000518	0.00101	CcSEcCtD
Aripiprazole—Erythema—Mesalazine—Crohn's disease	0.000515	0.001	CcSEcCtD
Aripiprazole—Malaise—Azathioprine—Crohn's disease	0.00051	0.000993	CcSEcCtD
Aripiprazole—Flatulence—Mesalazine—Crohn's disease	0.000507	0.000989	CcSEcCtD
Aripiprazole—Leukopenia—Azathioprine—Crohn's disease	0.000506	0.000986	CcSEcCtD
Aripiprazole—Tension—Mesalazine—Crohn's disease	0.000505	0.000985	CcSEcCtD
Aripiprazole—Dysgeusia—Mesalazine—Crohn's disease	0.000504	0.000983	CcSEcCtD
Aripiprazole—Nervousness—Mesalazine—Crohn's disease	0.0005	0.000975	CcSEcCtD
Aripiprazole—Back pain—Mesalazine—Crohn's disease	0.000498	0.000971	CcSEcCtD
Aripiprazole—Muscle spasms—Mesalazine—Crohn's disease	0.000495	0.000965	CcSEcCtD
Aripiprazole—Vomiting—Mercaptopurine—Crohn's disease	0.000492	0.000959	CcSEcCtD
Aripiprazole—Injury—Prednisone—Crohn's disease	0.000492	0.000959	CcSEcCtD
Aripiprazole—Rash—Mercaptopurine—Crohn's disease	0.000488	0.000951	CcSEcCtD
Aripiprazole—Dermatitis—Mercaptopurine—Crohn's disease	0.000488	0.00095	CcSEcCtD
Aripiprazole—Vision blurred—Mesalazine—Crohn's disease	0.000485	0.000946	CcSEcCtD
Aripiprazole—Tremor—Mesalazine—Crohn's disease	0.000482	0.00094	CcSEcCtD
Aripiprazole—Amnesia—Prednisone—Crohn's disease	0.000482	0.000938	CcSEcCtD
Aripiprazole—Increased appetite—Prednisone—Crohn's disease	0.000482	0.000938	CcSEcCtD
Aripiprazole—Arthralgia—Azathioprine—Crohn's disease	0.000481	0.000938	CcSEcCtD
Aripiprazole—Myalgia—Azathioprine—Crohn's disease	0.000481	0.000938	CcSEcCtD
Aripiprazole—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.000478	0.000931	CcSEcCtD
Aripiprazole—Ill-defined disorder—Mesalazine—Crohn's disease	0.000478	0.000931	CcSEcCtD
Aripiprazole—Anaemia—Mesalazine—Crohn's disease	0.000476	0.000927	CcSEcCtD
Aripiprazole—Discomfort—Azathioprine—Crohn's disease	0.000476	0.000927	CcSEcCtD
Aripiprazole—Angioedema—Mesalazine—Crohn's disease	0.000471	0.000917	CcSEcCtD
Aripiprazole—Purpura—Prednisone—Crohn's disease	0.000469	0.000915	CcSEcCtD
Aripiprazole—Malaise—Mesalazine—Crohn's disease	0.000464	0.000905	CcSEcCtD
Aripiprazole—Cardiac failure—Prednisone—Crohn's disease	0.000464	0.000903	CcSEcCtD
Aripiprazole—Vertigo—Mesalazine—Crohn's disease	0.000463	0.000901	CcSEcCtD
Aripiprazole—Syncope—Mesalazine—Crohn's disease	0.000462	0.0009	CcSEcCtD
Aripiprazole—Lethargy—Prednisone—Crohn's disease	0.000462	0.0009	CcSEcCtD
Aripiprazole—Leukopenia—Mesalazine—Crohn's disease	0.000461	0.000898	CcSEcCtD
Aripiprazole—Nausea—Mercaptopurine—Crohn's disease	0.00046	0.000896	CcSEcCtD
Aripiprazole—Infection—Azathioprine—Crohn's disease	0.000458	0.000893	CcSEcCtD
Aripiprazole—Palpitations—Mesalazine—Crohn's disease	0.000455	0.000887	CcSEcCtD
Aripiprazole—Loss of consciousness—Mesalazine—Crohn's disease	0.000453	0.000882	CcSEcCtD
Aripiprazole—Gastrointestinal haemorrhage—Prednisone—Crohn's disease	0.000452	0.000882	CcSEcCtD
Aripiprazole—Osteoarthritis—Prednisone—Crohn's disease	0.000452	0.000882	CcSEcCtD
Aripiprazole—Thrombocytopenia—Azathioprine—Crohn's disease	0.000452	0.00088	CcSEcCtD
Aripiprazole—Cough—Mesalazine—Crohn's disease	0.000449	0.000876	CcSEcCtD
Aripiprazole—Skin disorder—Azathioprine—Crohn's disease	0.000448	0.000873	CcSEcCtD
Aripiprazole—Affect lability—Prednisone—Crohn's disease	0.000445	0.000868	CcSEcCtD
Aripiprazole—Hypertension—Mesalazine—Crohn's disease	0.000445	0.000866	CcSEcCtD
Aripiprazole—Psychotic disorder—Prednisone—Crohn's disease	0.000442	0.000861	CcSEcCtD
Aripiprazole—Chest pain—Mesalazine—Crohn's disease	0.000438	0.000854	CcSEcCtD
Aripiprazole—Myalgia—Mesalazine—Crohn's disease	0.000438	0.000854	CcSEcCtD
Aripiprazole—Arthralgia—Mesalazine—Crohn's disease	0.000438	0.000854	CcSEcCtD
Aripiprazole—Anxiety—Mesalazine—Crohn's disease	0.000437	0.000851	CcSEcCtD
Aripiprazole—Face oedema—Prednisone—Crohn's disease	0.000437	0.000851	CcSEcCtD
Aripiprazole—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.000435	0.000848	CcSEcCtD
Aripiprazole—Discomfort—Mesalazine—Crohn's disease	0.000433	0.000844	CcSEcCtD
Aripiprazole—Irritability—Prednisone—Crohn's disease	0.000432	0.000841	CcSEcCtD
Aripiprazole—Hypotension—Azathioprine—Crohn's disease	0.000431	0.00084	CcSEcCtD
Aripiprazole—Cardiac arrest—Prednisone—Crohn's disease	0.00043	0.000838	CcSEcCtD
Aripiprazole—Dry mouth—Mesalazine—Crohn's disease	0.000429	0.000835	CcSEcCtD
Aripiprazole—Mood swings—Prednisone—Crohn's disease	0.000429	0.000835	CcSEcCtD
Aripiprazole—Confusional state—Mesalazine—Crohn's disease	0.000424	0.000826	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.00042	0.000819	CcSEcCtD
Aripiprazole—Anaphylactic shock—Mesalazine—Crohn's disease	0.00042	0.000819	CcSEcCtD
Aripiprazole—Oedema—Mesalazine—Crohn's disease	0.00042	0.000819	CcSEcCtD
Aripiprazole—Infection—Mesalazine—Crohn's disease	0.000418	0.000814	CcSEcCtD
Aripiprazole—Dry skin—Prednisone—Crohn's disease	0.000415	0.000808	CcSEcCtD
Aripiprazole—Shock—Mesalazine—Crohn's disease	0.000413	0.000806	CcSEcCtD
Aripiprazole—Nervous system disorder—Mesalazine—Crohn's disease	0.000412	0.000803	CcSEcCtD
Aripiprazole—Hypokalaemia—Prednisone—Crohn's disease	0.000412	0.000802	CcSEcCtD
Aripiprazole—Thrombocytopenia—Mesalazine—Crohn's disease	0.000412	0.000802	CcSEcCtD
Aripiprazole—Tachycardia—Mesalazine—Crohn's disease	0.00041	0.000799	CcSEcCtD
Aripiprazole—Skin disorder—Mesalazine—Crohn's disease	0.000408	0.000795	CcSEcCtD
Aripiprazole—Hyperhidrosis—Mesalazine—Crohn's disease	0.000406	0.000792	CcSEcCtD
Aripiprazole—Anorexia—Mesalazine—Crohn's disease	0.000401	0.000781	CcSEcCtD
Aripiprazole—Alanine aminotransferase increased—Prednisone—Crohn's disease	0.000399	0.000777	CcSEcCtD
Aripiprazole—Muscular weakness—Prednisone—Crohn's disease	0.000399	0.000777	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.000398	0.000776	CcSEcCtD
Aripiprazole—Abdominal distension—Prednisone—Crohn's disease	0.000394	0.000767	CcSEcCtD
Aripiprazole—Hypotension—Mesalazine—Crohn's disease	0.000393	0.000765	CcSEcCtD
Aripiprazole—Pancreatitis—Prednisone—Crohn's disease	0.000383	0.000747	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000383	0.000746	CcSEcCtD
Aripiprazole—Feeling abnormal—Azathioprine—Crohn's disease	0.00038	0.000741	CcSEcCtD
Aripiprazole—Insomnia—Mesalazine—Crohn's disease	0.00038	0.000741	CcSEcCtD
Aripiprazole—Paraesthesia—Mesalazine—Crohn's disease	0.000377	0.000735	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000377	0.000735	CcSEcCtD
Aripiprazole—Dyspnoea—Mesalazine—Crohn's disease	0.000375	0.00073	CcSEcCtD
Aripiprazole—Somnolence—Mesalazine—Crohn's disease	0.000374	0.000728	CcSEcCtD
Aripiprazole—Dyspepsia—Mesalazine—Crohn's disease	0.00037	0.000721	CcSEcCtD
Aripiprazole—Neutropenia—Prednisone—Crohn's disease	0.000366	0.000712	CcSEcCtD
Aripiprazole—Decreased appetite—Mesalazine—Crohn's disease	0.000365	0.000712	CcSEcCtD
Aripiprazole—Abdominal pain—Azathioprine—Crohn's disease	0.000365	0.000711	CcSEcCtD
Aripiprazole—Body temperature increased—Azathioprine—Crohn's disease	0.000365	0.000711	CcSEcCtD
Aripiprazole—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.000363	0.000707	CcSEcCtD
Aripiprazole—Fatigue—Mesalazine—Crohn's disease	0.000362	0.000706	CcSEcCtD
Aripiprazole—Erectile dysfunction—Prednisone—Crohn's disease	0.00036	0.000702	CcSEcCtD
Aripiprazole—Pain—Mesalazine—Crohn's disease	0.000359	0.0007	CcSEcCtD
Aripiprazole—Constipation—Mesalazine—Crohn's disease	0.000359	0.0007	CcSEcCtD
Aripiprazole—Weight increased—Prednisone—Crohn's disease	0.000356	0.000693	CcSEcCtD
Aripiprazole—Weight decreased—Prednisone—Crohn's disease	0.000354	0.000689	CcSEcCtD
Aripiprazole—Hyperglycaemia—Prednisone—Crohn's disease	0.000353	0.000687	CcSEcCtD
Aripiprazole—Depression—Prednisone—Crohn's disease	0.000348	0.000677	CcSEcCtD
Aripiprazole—Feeling abnormal—Mesalazine—Crohn's disease	0.000346	0.000675	CcSEcCtD
Aripiprazole—Acute coronary syndrome—Prednisone—Crohn's disease	0.000344	0.00067	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000344	0.00067	CcSEcCtD
Aripiprazole—Myocardial infarction—Prednisone—Crohn's disease	0.000342	0.000666	CcSEcCtD
Aripiprazole—Neuropathy peripheral—Prednisone—Crohn's disease	0.000342	0.000666	CcSEcCtD
Aripiprazole—Hypersensitivity—Azathioprine—Crohn's disease	0.00034	0.000662	CcSEcCtD
Aripiprazole—Urticaria—Mesalazine—Crohn's disease	0.000334	0.000651	CcSEcCtD
Aripiprazole—Abdominal pain—Mesalazine—Crohn's disease	0.000332	0.000647	CcSEcCtD
Aripiprazole—Body temperature increased—Mesalazine—Crohn's disease	0.000332	0.000647	CcSEcCtD
Aripiprazole—Bradycardia—Prednisone—Crohn's disease	0.000319	0.000621	CcSEcCtD
Aripiprazole—ABCB1—lymph node—Crohn's disease	0.000316	0.00148	CbGeAlD
Aripiprazole—Diarrhoea—Azathioprine—Crohn's disease	0.000316	0.000615	CcSEcCtD
Aripiprazole—Haemoglobin—Prednisone—Crohn's disease	0.000315	0.000613	CcSEcCtD
Aripiprazole—Haemorrhage—Prednisone—Crohn's disease	0.000313	0.00061	CcSEcCtD
Aripiprazole—Hallucination—Prednisone—Crohn's disease	0.000311	0.000607	CcSEcCtD
Aripiprazole—Hypersensitivity—Mesalazine—Crohn's disease	0.00031	0.000603	CcSEcCtD
Aripiprazole—Connective tissue disorder—Prednisone—Crohn's disease	0.000308	0.000599	CcSEcCtD
Aripiprazole—Dizziness—Azathioprine—Crohn's disease	0.000305	0.000594	CcSEcCtD
Aripiprazole—Asthenia—Mesalazine—Crohn's disease	0.000302	0.000588	CcSEcCtD
Aripiprazole—Pruritus—Mesalazine—Crohn's disease	0.000297	0.000579	CcSEcCtD
Aripiprazole—Vomiting—Azathioprine—Crohn's disease	0.000293	0.000572	CcSEcCtD
Aripiprazole—Eye disorder—Prednisone—Crohn's disease	0.000292	0.00057	CcSEcCtD
Aripiprazole—Rash—Azathioprine—Crohn's disease	0.000291	0.000567	CcSEcCtD
Aripiprazole—Dermatitis—Azathioprine—Crohn's disease	0.000291	0.000566	CcSEcCtD
Aripiprazole—Flushing—Prednisone—Crohn's disease	0.00029	0.000566	CcSEcCtD
Aripiprazole—Headache—Azathioprine—Crohn's disease	0.000289	0.000563	CcSEcCtD
Aripiprazole—Diarrhoea—Mesalazine—Crohn's disease	0.000288	0.00056	CcSEcCtD
Aripiprazole—Angiopathy—Prednisone—Crohn's disease	0.000284	0.000553	CcSEcCtD
Aripiprazole—Immune system disorder—Prednisone—Crohn's disease	0.000283	0.000551	CcSEcCtD
Aripiprazole—Dizziness—Mesalazine—Crohn's disease	0.000278	0.000542	CcSEcCtD
Aripiprazole—Alopecia—Prednisone—Crohn's disease	0.000277	0.000539	CcSEcCtD
Aripiprazole—Mental disorder—Prednisone—Crohn's disease	0.000274	0.000534	CcSEcCtD
Aripiprazole—Nausea—Azathioprine—Crohn's disease	0.000274	0.000534	CcSEcCtD
Aripiprazole—Malnutrition—Prednisone—Crohn's disease	0.000272	0.000531	CcSEcCtD
Aripiprazole—Erythema—Prednisone—Crohn's disease	0.000272	0.000531	CcSEcCtD
Aripiprazole—Vomiting—Mesalazine—Crohn's disease	0.000267	0.000521	CcSEcCtD
Aripiprazole—Rash—Mesalazine—Crohn's disease	0.000265	0.000516	CcSEcCtD
Aripiprazole—Dermatitis—Mesalazine—Crohn's disease	0.000265	0.000516	CcSEcCtD
Aripiprazole—Headache—Mesalazine—Crohn's disease	0.000263	0.000513	CcSEcCtD
Aripiprazole—Vision blurred—Prednisone—Crohn's disease	0.000257	0.0005	CcSEcCtD
Aripiprazole—Ill-defined disorder—Prednisone—Crohn's disease	0.000253	0.000493	CcSEcCtD
Aripiprazole—Anaemia—Prednisone—Crohn's disease	0.000252	0.000491	CcSEcCtD
Aripiprazole—Agitation—Prednisone—Crohn's disease	0.00025	0.000488	CcSEcCtD
Aripiprazole—Nausea—Mesalazine—Crohn's disease	0.00025	0.000486	CcSEcCtD
Aripiprazole—Angioedema—Prednisone—Crohn's disease	0.000249	0.000485	CcSEcCtD
Aripiprazole—Malaise—Prednisone—Crohn's disease	0.000246	0.000479	CcSEcCtD
Aripiprazole—Vertigo—Prednisone—Crohn's disease	0.000245	0.000477	CcSEcCtD
Aripiprazole—Syncope—Prednisone—Crohn's disease	0.000244	0.000476	CcSEcCtD
Aripiprazole—Loss of consciousness—Prednisone—Crohn's disease	0.000239	0.000467	CcSEcCtD
Aripiprazole—Convulsion—Prednisone—Crohn's disease	0.000236	0.00046	CcSEcCtD
Aripiprazole—Hypertension—Prednisone—Crohn's disease	0.000235	0.000458	CcSEcCtD
Aripiprazole—Arthralgia—Prednisone—Crohn's disease	0.000232	0.000452	CcSEcCtD
Aripiprazole—Myalgia—Prednisone—Crohn's disease	0.000232	0.000452	CcSEcCtD
Aripiprazole—Anxiety—Prednisone—Crohn's disease	0.000231	0.00045	CcSEcCtD
Aripiprazole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.00023	0.000449	CcSEcCtD
Aripiprazole—Discomfort—Prednisone—Crohn's disease	0.000229	0.000447	CcSEcCtD
Aripiprazole—Anaphylactic shock—Prednisone—Crohn's disease	0.000222	0.000433	CcSEcCtD
Aripiprazole—Oedema—Prednisone—Crohn's disease	0.000222	0.000433	CcSEcCtD
Aripiprazole—Infection—Prednisone—Crohn's disease	0.000221	0.00043	CcSEcCtD
Aripiprazole—Shock—Prednisone—Crohn's disease	0.000219	0.000426	CcSEcCtD
Aripiprazole—Nervous system disorder—Prednisone—Crohn's disease	0.000218	0.000425	CcSEcCtD
Aripiprazole—Tachycardia—Prednisone—Crohn's disease	0.000217	0.000423	CcSEcCtD
Aripiprazole—Skin disorder—Prednisone—Crohn's disease	0.000216	0.000421	CcSEcCtD
Aripiprazole—Hyperhidrosis—Prednisone—Crohn's disease	0.000215	0.000419	CcSEcCtD
Aripiprazole—Anorexia—Prednisone—Crohn's disease	0.000212	0.000413	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000203	0.000395	CcSEcCtD
Aripiprazole—Insomnia—Prednisone—Crohn's disease	0.000201	0.000392	CcSEcCtD
Aripiprazole—Paraesthesia—Prednisone—Crohn's disease	0.0002	0.000389	CcSEcCtD
Aripiprazole—Dyspepsia—Prednisone—Crohn's disease	0.000196	0.000381	CcSEcCtD
Aripiprazole—Decreased appetite—Prednisone—Crohn's disease	0.000193	0.000377	CcSEcCtD
Aripiprazole—Fatigue—Prednisone—Crohn's disease	0.000192	0.000374	CcSEcCtD
Aripiprazole—Constipation—Prednisone—Crohn's disease	0.00019	0.00037	CcSEcCtD
Aripiprazole—Feeling abnormal—Prednisone—Crohn's disease	0.000183	0.000357	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Prednisone—Crohn's disease	0.000182	0.000354	CcSEcCtD
Aripiprazole—Urticaria—Prednisone—Crohn's disease	0.000177	0.000344	CcSEcCtD
Aripiprazole—Body temperature increased—Prednisone—Crohn's disease	0.000176	0.000342	CcSEcCtD
Aripiprazole—Abdominal pain—Prednisone—Crohn's disease	0.000176	0.000342	CcSEcCtD
Aripiprazole—Hypersensitivity—Prednisone—Crohn's disease	0.000164	0.000319	CcSEcCtD
Aripiprazole—Asthenia—Prednisone—Crohn's disease	0.00016	0.000311	CcSEcCtD
Aripiprazole—Pruritus—Prednisone—Crohn's disease	0.000157	0.000307	CcSEcCtD
Aripiprazole—Diarrhoea—Prednisone—Crohn's disease	0.000152	0.000296	CcSEcCtD
Aripiprazole—Dizziness—Prednisone—Crohn's disease	0.000147	0.000287	CcSEcCtD
Aripiprazole—Vomiting—Prednisone—Crohn's disease	0.000141	0.000275	CcSEcCtD
Aripiprazole—Rash—Prednisone—Crohn's disease	0.00014	0.000273	CcSEcCtD
Aripiprazole—Dermatitis—Prednisone—Crohn's disease	0.00014	0.000273	CcSEcCtD
Aripiprazole—Headache—Prednisone—Crohn's disease	0.000139	0.000271	CcSEcCtD
Aripiprazole—Nausea—Prednisone—Crohn's disease	0.000132	0.000257	CcSEcCtD
Aripiprazole—ADRB1—Signaling by GPCR—CXCL8—Crohn's disease	2.26e-05	8.27e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—RASGRP1—Crohn's disease	2.26e-05	8.26e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling by GPCR—JAK2—Crohn's disease	2.26e-05	8.25e-05	CbGpPWpGaD
Aripiprazole—HTR2A—GPCR downstream signaling—JAK2—Crohn's disease	2.26e-05	8.24e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—SOCS1—Crohn's disease	2.25e-05	8.23e-05	CbGpPWpGaD
Aripiprazole—HRH1—GPCR downstream signaling—JAK2—Crohn's disease	2.25e-05	8.22e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—SMAD3—Crohn's disease	2.25e-05	8.22e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—SOCS1—Crohn's disease	2.25e-05	8.21e-05	CbGpPWpGaD
Aripiprazole—CHRM1—GPCR downstream signaling—JAK2—Crohn's disease	2.24e-05	8.2e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling by GPCR—CXCL8—Crohn's disease	2.24e-05	8.19e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—SOCS1—Crohn's disease	2.24e-05	8.18e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—SMAD3—Crohn's disease	2.24e-05	8.18e-05	CbGpPWpGaD
Aripiprazole—DRD5—Signaling Pathways—CXCL8—Crohn's disease	2.24e-05	8.17e-05	CbGpPWpGaD
Aripiprazole—CHRM3—GPCR downstream signaling—JAK2—Crohn's disease	2.24e-05	8.17e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—SOCS1—Crohn's disease	2.23e-05	8.16e-05	CbGpPWpGaD
Aripiprazole—CHRM2—GPCR downstream signaling—JAK2—Crohn's disease	2.22e-05	8.09e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—SOCS1—Crohn's disease	2.21e-05	8.08e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—GPCR downstream signaling—JAK2—Crohn's disease	2.21e-05	8.07e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—SOCS1—Crohn's disease	2.21e-05	8.06e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling by GPCR—TYK2—Crohn's disease	2.18e-05	7.97e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—IL2RA—Crohn's disease	2.18e-05	7.96e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—SMAD3—Crohn's disease	2.18e-05	7.96e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling by GPCR—CXCL8—Crohn's disease	2.16e-05	7.91e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—IL2RA—Crohn's disease	2.16e-05	7.89e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling by GPCR—CXCL8—Crohn's disease	2.15e-05	7.87e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling by GPCR—TYK2—Crohn's disease	2.15e-05	7.84e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—SMAD3—Crohn's disease	2.14e-05	7.83e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling by GPCR—TYK2—Crohn's disease	2.14e-05	7.83e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling by GPCR—TYK2—Crohn's disease	2.14e-05	7.8e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling by GPCR—TYK2—Crohn's disease	2.13e-05	7.78e-05	CbGpPWpGaD
Aripiprazole—DRD5—Signaling by GPCR—IL6—Crohn's disease	2.13e-05	7.77e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling by GPCR—TYK2—Crohn's disease	2.11e-05	7.7e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling by GPCR—TYK2—Crohn's disease	2.1e-05	7.68e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—FADS1—Crohn's disease	2.1e-05	7.66e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling by GPCR—CXCL8—Crohn's disease	2.09e-05	7.65e-05	CbGpPWpGaD
Aripiprazole—DRD2—GPCR downstream signaling—CXCL8—Crohn's disease	2.09e-05	7.64e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	2.09e-05	7.64e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—IL2RA—Crohn's disease	2.08e-05	7.61e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling by GPCR—JAK2—Crohn's disease	2.08e-05	7.61e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—IL2RA—Crohn's disease	2.07e-05	7.57e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling by GPCR—CXCL8—Crohn's disease	2.06e-05	7.53e-05	CbGpPWpGaD
Aripiprazole—HTR2A—GPCR downstream signaling—CXCL8—Crohn's disease	2.06e-05	7.52e-05	CbGpPWpGaD
Aripiprazole—HRH1—GPCR downstream signaling—CXCL8—Crohn's disease	2.05e-05	7.5e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—GPCR downstream signaling—JAK2—Crohn's disease	2.05e-05	7.5e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—SOCS1—Crohn's disease	2.05e-05	7.48e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling by GPCR—JAK2—Crohn's disease	2.05e-05	7.48e-05	CbGpPWpGaD
Aripiprazole—CHRM1—GPCR downstream signaling—CXCL8—Crohn's disease	2.05e-05	7.48e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling by GPCR—JAK2—Crohn's disease	2.04e-05	7.47e-05	CbGpPWpGaD
Aripiprazole—CHRM3—GPCR downstream signaling—CXCL8—Crohn's disease	2.04e-05	7.46e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling by GPCR—JAK2—Crohn's disease	2.04e-05	7.44e-05	CbGpPWpGaD
Aripiprazole—HTR1E—Signaling Pathways—STAT3—Crohn's disease	2.03e-05	7.43e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling by GPCR—JAK2—Crohn's disease	2.03e-05	7.42e-05	CbGpPWpGaD
Aripiprazole—CHRM2—GPCR downstream signaling—CXCL8—Crohn's disease	2.02e-05	7.38e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—IL2RA—Crohn's disease	2.02e-05	7.37e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—GPCR downstream signaling—CXCL8—Crohn's disease	2.02e-05	7.36e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling by GPCR—JAK2—Crohn's disease	2.01e-05	7.35e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling by GPCR—JAK2—Crohn's disease	2.01e-05	7.33e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—IL2RA—Crohn's disease	1.99e-05	7.25e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—TYK2—Crohn's disease	1.98e-05	7.25e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—TYK2—Crohn's disease	1.98e-05	7.24e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—SMAD3—Crohn's disease	1.98e-05	7.22e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—TYK2—Crohn's disease	1.97e-05	7.19e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—GPX4—Crohn's disease	1.96e-05	7.17e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—TYK2—Crohn's disease	1.95e-05	7.14e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—SMAD3—Crohn's disease	1.94e-05	7.1e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—SMAD3—Crohn's disease	1.94e-05	7.09e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—SMAD3—Crohn's disease	1.93e-05	7.07e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—SMAD3—Crohn's disease	1.93e-05	7.04e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—TYK2—Crohn's disease	1.93e-05	7.04e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—SMAD3—Crohn's disease	1.91e-05	6.97e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—SMAD3—Crohn's disease	1.9e-05	6.96e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling by GPCR—CXCL8—Crohn's disease	1.9e-05	6.94e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—TYK2—Crohn's disease	1.9e-05	6.93e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—GCKR—Crohn's disease	1.9e-05	6.93e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—JAK2—Crohn's disease	1.89e-05	6.91e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—JAK2—Crohn's disease	1.89e-05	6.91e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—JAK2—Crohn's disease	1.88e-05	6.86e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—GPCR downstream signaling—CXCL8—Crohn's disease	1.87e-05	6.84e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—TYK2—Crohn's disease	1.87e-05	6.84e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling by GPCR—CXCL8—Crohn's disease	1.87e-05	6.83e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling by GPCR—CXCL8—Crohn's disease	1.87e-05	6.82e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—JAK2—Crohn's disease	1.86e-05	6.81e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling by GPCR—CXCL8—Crohn's disease	1.86e-05	6.79e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling by GPCR—CXCL8—Crohn's disease	1.85e-05	6.77e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—JAK2—Crohn's disease	1.84e-05	6.72e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling by GPCR—CXCL8—Crohn's disease	1.84e-05	6.71e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling by GPCR—CXCL8—Crohn's disease	1.83e-05	6.69e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—IL2RA—Crohn's disease	1.83e-05	6.68e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—TYK2—Crohn's disease	1.81e-05	6.61e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—JAK2—Crohn's disease	1.81e-05	6.61e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—IL2RA—Crohn's disease	1.8e-05	6.58e-05	CbGpPWpGaD
Aripiprazole—DRD5—Signaling Pathways—STAT3—Crohn's disease	1.8e-05	6.57e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—IL2RA—Crohn's disease	1.8e-05	6.56e-05	CbGpPWpGaD
Aripiprazole—CYP3A7—Metabolism—ALB—Crohn's disease	1.8e-05	6.56e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—TYK2—Crohn's disease	1.79e-05	6.55e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—IL2RA—Crohn's disease	1.79e-05	6.54e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—JAK2—Crohn's disease	1.79e-05	6.52e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—IL2RA—Crohn's disease	1.79e-05	6.52e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—SMAD3—Crohn's disease	1.77e-05	6.46e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—IL2RA—Crohn's disease	1.77e-05	6.46e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—IL2RA—Crohn's disease	1.76e-05	6.44e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Metabolism—ALB—Crohn's disease	1.74e-05	6.37e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—JAK2—Crohn's disease	1.73e-05	6.31e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—CXCL8—Crohn's disease	1.73e-05	6.31e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—CXCL8—Crohn's disease	1.73e-05	6.3e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—CXCL8—Crohn's disease	1.71e-05	6.26e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—JAK2—Crohn's disease	1.71e-05	6.24e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—TYK2—Crohn's disease	1.71e-05	6.24e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—CXCL8—Crohn's disease	1.7e-05	6.21e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—TYK2—Crohn's disease	1.69e-05	6.15e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—CXCL8—Crohn's disease	1.68e-05	6.13e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—CXCL8—Crohn's disease	1.65e-05	6.03e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling by GPCR—IL6—Crohn's disease	1.64e-05	6e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling by GPCR—IL6—Crohn's disease	1.64e-05	5.99e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—IL2RA—Crohn's disease	1.64e-05	5.98e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling by GPCR—IL6—Crohn's disease	1.63e-05	5.95e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—CXCL8—Crohn's disease	1.63e-05	5.95e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—JAK2—Crohn's disease	1.63e-05	5.95e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—JAK2—Crohn's disease	1.61e-05	5.87e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling by GPCR—IL6—Crohn's disease	1.6e-05	5.83e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—CXCL8—Crohn's disease	1.58e-05	5.76e-05	CbGpPWpGaD
Aripiprazole—CYP3A7—Metabolism—PTGS2—Crohn's disease	1.57e-05	5.74e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling by GPCR—IL6—Crohn's disease	1.57e-05	5.74e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—CXCL8—Crohn's disease	1.56e-05	5.7e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling by GPCR—IL6—Crohn's disease	1.55e-05	5.66e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Metabolism—ALB—Crohn's disease	1.54e-05	5.64e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—TYK2—Crohn's disease	1.54e-05	5.61e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Metabolism—PTGS2—Crohn's disease	1.53e-05	5.57e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—TYK2—Crohn's disease	1.52e-05	5.56e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling by GPCR—IL6—Crohn's disease	1.5e-05	5.48e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—CXCL8—Crohn's disease	1.49e-05	5.43e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling by GPCR—IL6—Crohn's disease	1.48e-05	5.42e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—TYK2—Crohn's disease	1.47e-05	5.36e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—CXCL8—Crohn's disease	1.47e-05	5.36e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—JAK2—Crohn's disease	1.46e-05	5.35e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—TYK2—Crohn's disease	1.46e-05	5.34e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—JAK2—Crohn's disease	1.45e-05	5.3e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—TYK2—Crohn's disease	1.42e-05	5.19e-05	CbGpPWpGaD
Aripiprazole—HTR1E—Signaling Pathways—IL6—Crohn's disease	1.42e-05	5.19e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—ALB—Crohn's disease	1.42e-05	5.17e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling by GPCR—IL6—Crohn's disease	1.41e-05	5.16e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—JAK2—Crohn's disease	1.4e-05	5.12e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—TYK2—Crohn's disease	1.4e-05	5.11e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling by GPCR—IL6—Crohn's disease	1.4e-05	5.1e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—JAK2—Crohn's disease	1.39e-05	5.09e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—STAT3—Crohn's disease	1.39e-05	5.07e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—STAT3—Crohn's disease	1.39e-05	5.07e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—STAT3—Crohn's disease	1.38e-05	5.04e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—JAK2—Crohn's disease	1.36e-05	4.95e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Metabolism—PTGS2—Crohn's disease	1.35e-05	4.93e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—STAT3—Crohn's disease	1.35e-05	4.93e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—CXCL8—Crohn's disease	1.34e-05	4.88e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—JAK2—Crohn's disease	1.33e-05	4.87e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—STAT3—Crohn's disease	1.33e-05	4.85e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—CXCL8—Crohn's disease	1.32e-05	4.84e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—STAT3—Crohn's disease	1.31e-05	4.79e-05	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—ALB—Crohn's disease	1.3e-05	4.74e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—TYK2—Crohn's disease	1.29e-05	4.71e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—CXCL8—Crohn's disease	1.28e-05	4.67e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—CXCL8—Crohn's disease	1.27e-05	4.65e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling by GPCR—IL6—Crohn's disease	1.27e-05	4.64e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—TYK2—Crohn's disease	1.27e-05	4.63e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—STAT3—Crohn's disease	1.27e-05	4.63e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—TYK2—Crohn's disease	1.27e-05	4.62e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—TYK2—Crohn's disease	1.26e-05	4.61e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling by GPCR—IL6—Crohn's disease	1.26e-05	4.6e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—TYK2—Crohn's disease	1.26e-05	4.59e-05	CbGpPWpGaD
Aripiprazole—DRD5—Signaling Pathways—IL6—Crohn's disease	1.26e-05	4.59e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—STAT3—Crohn's disease	1.26e-05	4.58e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—TYK2—Crohn's disease	1.25e-05	4.55e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—TYK2—Crohn's disease	1.24e-05	4.54e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—PTGS2—Crohn's disease	1.24e-05	4.53e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—CXCL8—Crohn's disease	1.24e-05	4.52e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—JAK2—Crohn's disease	1.23e-05	4.49e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—CXCL8—Crohn's disease	1.22e-05	4.45e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling by GPCR—IL6—Crohn's disease	1.22e-05	4.44e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—JAK2—Crohn's disease	1.21e-05	4.42e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling by GPCR—IL6—Crohn's disease	1.21e-05	4.42e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—JAK2—Crohn's disease	1.21e-05	4.41e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—JAK2—Crohn's disease	1.2e-05	4.4e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—JAK2—Crohn's disease	1.2e-05	4.38e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—STAT3—Crohn's disease	1.2e-05	4.37e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—JAK2—Crohn's disease	1.19e-05	4.34e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—JAK2—Crohn's disease	1.19e-05	4.33e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—STAT3—Crohn's disease	1.18e-05	4.31e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling by GPCR—IL6—Crohn's disease	1.18e-05	4.3e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling by GPCR—IL6—Crohn's disease	1.16e-05	4.23e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—TYK2—Crohn's disease	1.15e-05	4.22e-05	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—PTGS2—Crohn's disease	1.14e-05	4.15e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—CXCL8—Crohn's disease	1.12e-05	4.1e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—CXCL8—Crohn's disease	1.1e-05	4.03e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—CXCL8—Crohn's disease	1.1e-05	4.03e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—JAK2—Crohn's disease	1.1e-05	4.02e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—CXCL8—Crohn's disease	1.1e-05	4.01e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—CXCL8—Crohn's disease	1.1e-05	4e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—CXCL8—Crohn's disease	1.08e-05	3.96e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—CXCL8—Crohn's disease	1.08e-05	3.95e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—STAT3—Crohn's disease	1.08e-05	3.93e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling by GPCR—IL6—Crohn's disease	1.07e-05	3.9e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—STAT3—Crohn's disease	1.07e-05	3.89e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling by GPCR—IL6—Crohn's disease	1.05e-05	3.84e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling by GPCR—IL6—Crohn's disease	1.05e-05	3.83e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling by GPCR—IL6—Crohn's disease	1.04e-05	3.82e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling by GPCR—IL6—Crohn's disease	1.04e-05	3.8e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling by GPCR—IL6—Crohn's disease	1.03e-05	3.77e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling by GPCR—IL6—Crohn's disease	1.03e-05	3.76e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—STAT3—Crohn's disease	1.03e-05	3.76e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—STAT3—Crohn's disease	1.02e-05	3.74e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—CXCL8—Crohn's disease	1.01e-05	3.67e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—STAT3—Crohn's disease	9.95e-06	3.63e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—ALB—Crohn's disease	9.8e-06	3.58e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—STAT3—Crohn's disease	9.79e-06	3.58e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—IL6—Crohn's disease	9.7e-06	3.54e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—IL6—Crohn's disease	9.69e-06	3.54e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—IL6—Crohn's disease	9.63e-06	3.52e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—IL6—Crohn's disease	9.56e-06	3.49e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—IL6—Crohn's disease	9.43e-06	3.44e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—IL6—Crohn's disease	9.28e-06	3.39e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—ALB—Crohn's disease	9.23e-06	3.37e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—IL6—Crohn's disease	9.15e-06	3.34e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—STAT3—Crohn's disease	9.03e-06	3.3e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—STAT3—Crohn's disease	8.88e-06	3.24e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—STAT3—Crohn's disease	8.86e-06	3.24e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—IL6—Crohn's disease	8.86e-06	3.24e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—STAT3—Crohn's disease	8.84e-06	3.23e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—STAT3—Crohn's disease	8.81e-06	3.22e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—IL6—Crohn's disease	8.77e-06	3.2e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—STAT3—Crohn's disease	8.72e-06	3.19e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—STAT3—Crohn's disease	8.7e-06	3.18e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—PTGS2—Crohn's disease	8.57e-06	3.13e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—IL6—Crohn's disease	8.35e-06	3.05e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—IL6—Crohn's disease	8.24e-06	3.01e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—STAT3—Crohn's disease	8.08e-06	2.95e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—PTGS2—Crohn's disease	8.08e-06	2.95e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—IL6—Crohn's disease	7.51e-06	2.74e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—IL6—Crohn's disease	7.44e-06	2.72e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—IL6—Crohn's disease	7.18e-06	2.62e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—IL6—Crohn's disease	7.15e-06	2.61e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—IL6—Crohn's disease	6.95e-06	2.54e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—IL6—Crohn's disease	6.84e-06	2.5e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—IL6—Crohn's disease	6.31e-06	2.3e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—IL6—Crohn's disease	6.21e-06	2.27e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—IL6—Crohn's disease	6.19e-06	2.26e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—IL6—Crohn's disease	6.17e-06	2.25e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—IL6—Crohn's disease	6.15e-06	2.25e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—IL6—Crohn's disease	6.09e-06	2.23e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—IL6—Crohn's disease	6.08e-06	2.22e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—ALB—Crohn's disease	6.04e-06	2.2e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—IL6—Crohn's disease	5.65e-06	2.06e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—PTGS2—Crohn's disease	5.28e-06	1.93e-05	CbGpPWpGaD
